Glucose-dependent insulinotropic polypeptide receptor therapies for the treatment of obesity, do agonists = antagonists
Sometimes people taking GLP-1 drugs dont feel thirsty and forget to drink water
As we move beyond singlevariant analyses and into polygenic and multiomic models, I expect well see far greater clinical relevance
Dumont BL, Neagoe P-E, Charles E, Villeneuve L, Ninni S, Tardif J-C, et al
We have previously shown that b-catenin-(encoded by CTNNB1 gene)-mutated HCC animal models developed via hydrodynamic tail vein injection with sleeping beauty transposon/transposase (SB-HDTVi) represent clinically relevant molecular subsets of human HCC
[DOI] [PubMed] [Google Scholar] 473.Rybak L.P., Ramkumar V